Author + information
- Received April 15, 2020
- Revision received April 29, 2020
- Accepted May 11, 2020
- Published online July 15, 2020.
- Connor O’Brien, MDa,∗∗ (, )@coobrien,
- Ning Ning, MDb,∗,
- James McAvoy, MDc,
- James E. Mitchell, MDa,
- Neil Kalwani, MDb,
- Paul Wang, MDb,
- Duy Nguyen, MDb,
- Risheen Reejhsinghani, MDb,
- Angela Rogers, MDa and
- Javier Lorenzo, MDc
- aDivision of Allergy, Pulmonology, and Critical Care Medicine, Stanford University, Stanford, California
- bDivision of Cardiovascular Medicine, Stanford University, Stanford, California
- cDivision of Anesthesiology, Perioperative, and Pain Medicine, Stanford University, Stanford, California
- ↵∗Address for correspondence:
Dr. Connor O’Brien, Stanford Hospital and Clinics, Department of Pulmonology, Allergy, and Critical Care Medicine, 300 Pasteur Drive, Room H3143, Stanford, California 94305.
COVID-19 is a global pandemic caused by SARS-CoV-2. Infection is associated with significant morbidity and mortality. Individuals with pre-existing cardiovascular disease or evidence of myocardial injury are at risk for severe disease and death. Little is understood about the mechanisms of myocardial injury or life-threatening cardiovascular sequelae. (Level of Difficulty: Intermediate.)
- preserved ejection fraction
- ventricular fibrillation
- ventricular tachycardia
↵∗ Drs. O’Brien and Ning contributed equally to this paper.
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Case Reports author instructions page.
- Received April 15, 2020.
- Revision received April 29, 2020.
- Accepted May 11, 2020.
- 2020 The Authors